Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1111

Endo-1,4-β-xylanase enzyme preparation produced by Bacillus subtilis expressing the gene encoding xylanase from B. subtilis

Intended Use: Intended for use as an enzyme at up to 50 mg total organic solids (TOS)/kg raw material in baking, brewing, and in grain processing.
Basis: Scientific procedures
Notifier: AB Enzymes Inc.
Notifier Address: 8212 W. Broward Blvd., Suite 375
Plantation, FL 33324
GRAS Notice (releasable information): GRN 1111 (in PDF) (3.2 MB)
Date of closure: Feb 15, 2024
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (136 kB)
-
-